PD-032 - Pharmacogenetic clinical randomized phase II trial to evaluate the efficacy and safety of FOLFIRI with high dose of irinotecan (FOLFIRI-HD) in metastatic colorectal cancer patients according to UGT1A 1 genotype
- Resource Type
- Abstract
- Source
- In
Annals of Oncology June 2017 28 Supplement 3:iii12-iii12 - Subject
- Language
- ISSN
- 0923-7534